CaNCURE Co-op Showcase

dsc_9827dsc_9836-1The CaNCURE Team would like to send out a congratulations to the 8 trainees who completed their CaNCURE co-op this December! We were so proud to see all your accomplishments at our second annual CaNCURE Co-op Showcase and to learn that for many of you, this co-op was a career-defining experience!

 

 


 

Upcoming Events

Save the Date! CaNCURE Nanomedicine Day is June 14, 2017!

Wednesday, June 14, 2017

Our third annual Nanomedicine Day will feature talks and posters by CaNCURE co-op students, Nanomedicine Academy students, and other graduate students performing nanomedicine research at Northeastern University.  We invite all faculty and students to join us on June 14th to celebrate the accomplishments of our Nanomedicine trainees! No registration is necessary to attend. To present a […]

John D. O'Bryant African-American Institute -- NEU, 12:00 PM


Mentor Spotlight


Robert N Hanson, Ph.D.

Matthews Distinguished University Professor, NEU

Our lab develops targeting strategies for highly specific delivery of nanoparticle- and molecule-based therapeutics to breast and prostate cancer. Students will study the selectivity of self-assembled polymeric nanoparticles to tumor cells by using a multimeric peptidomimetic nanoplatform comprised of tumor cell-specific amino acids.


Tayyaba Hasan, Ph.D.

Professor of Dermatology, HMS

Our group has extensive expertise in the photodynamic therapy of cancer, infections, and infectious disease, as well as targeted drug delivery using site-directed photochemistry. Students will participate in the design and testing of photoactivatable nanoparticles for the treatment of ovarian, prostate, pancreatic, or head and neck cancer.


Trainee Spotlight


Gabby Brauner

Health Science, '18

Online monitoring and image-guided treatment of chemoresistant micrometastases

Nicholas LoRocco

Biochemistry, '20

Quantitative Multimodal Imaging of Tumor Response to Radiation

John Berrigan

Health Science, '18

Use of a Triblock Copolymer Hydrogel for Controlled Release of Cisplatin and BMN-673


Going on in the lab right now...